Hypoglossal Nerve Stimulation for the Treatment of Adult Obstructive Sleep Apnea
NCT: NCT07049744 · RECRUITING
Brief Summary
The goal of this interventional study is to assess the safety and performance of the XII Medical Hypoglossal Nerve Stimulation (HGNS) System in people who have moderate to severe Obstructive Sleep Apnea (OSA). Participation in this study involves being implanted with a Neurostimulator which provides electrical stimulation of the hypoglossal nerve (HGN). Participants will receive treatment at home during sleep, and participate in sleep studies to track and record the quality of the sleep. Participants will be monitored over the course of the study.
Frequently Asked Questions
What is Hypoglossal Nerve Stimulation for the Treatment of Adult Obstructive Sleep Apnea?
Hypoglossal Nerve Stimulation for the Treatment of Adult Obstructive Sleep Apnea is a clinical trial registered under NCT07049744. Current status: RECRUITING.
What is the status of NCT07049744?
The current status of NCT07049744 (Hypoglossal Nerve Stimulation for the Treatment of Adult Obstructive Sleep Apnea) is: RECRUITING.
When did Hypoglossal Nerve Stimulation for the Treatment of Adult Obstructive Sleep Apnea start?
Hypoglossal Nerve Stimulation for the Treatment of Adult Obstructive Sleep Apnea started on 2025-06-24.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.